Physician
Pediatric Partners
Pediatric Partners was paid $2.52M by Medicaid between Jan 2018 and Dec 2024, across 47 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoPEDIATRIC PARTNERS
GLENWOOD SPRINGS, CO 81601
GLENWOOD SPRINGS, CO 81601
33aNPI1417162876assigned 05/11/2007
33bProvider typePediatrics Physician
28Total paid$2.52M
24GClaims52,040
24DCodes billed47
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Colorado
Rank by total paid#15 of 186
Median peer was paid$68K
This provider vs. median37×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,129 | $322K | |
| 2019 | 8,680 | $426K | |
| 2020 | 5,554 | $256K | |
| 2021 | 8,431 | $368K | |
| 2022 | 7,276 | $397K | |
| 2023 | 7,980 | $397K | |
| 2024incomplete | 6,990 | $352K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 12,448 | 10,981 | $823K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 5,113 | 4,362 | $480K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 15% | 4,633 | 4,231 | $387K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 15% | 10,133 | 7,999 | $383K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.6% | 2,363 | 2,158 | $218K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 674 | 605 | $31K |
| D0145 | Oral evaluation for a patient under three years of age | 1.2% | 1,018 | 951 | $30K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,431 | 1,347 | $25K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 589 | 549 | $24K |
| 90670 | <1% | 1,261 | 1,187 | $23K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 167 | 141 | $15K |
| 90686 | <1% | 3,604 | 3,312 | $11K |
35 more codes
| 0071A | <1% | 304 | $10K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 847 | $9K |
| 99173 | <1% | 1,404 | $9K | |
| 92583 | <1% | 448 | $8K | |
| 0072A | <1% | 188 | $7K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 242 | $4K |
| D1206 | Topical application of fluoride varnish | <1% | 183 | $2K |
| 90677 | <1% | 244 | $2K | |
| 99177 | <1% | 197 | $2K | |
| 90480 | <1% | 31 | $2K | |
| 90697 | <1% | 271 | $2K | |
| 96127 | <1% | 104 | $2K | |
| 90656 | <1% | 474 | $1K | |
| 36416 | <1% | 1,183 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 17 | $1K |
| 90723 | <1% | 97 | $946.82 | |
| 90685 | <1% | 288 | $867.29 | |
| 99174 | <1% | 66 | $825.15 | |
| 99460 | <1% | 18 | $787.05 | |
| 90647 | <1% | 258 | $753.14 | |
| 90681 | <1% | 73 | $748.78 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 12 | $707.06 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 15 | $512.96 |
| 99401 | <1% | 22 | $485.59 | |
| 92552 | <1% | 40 | $439.96 | |
| 90461 | <1% | 22 | $435.10 | |
| 83655 | <1% | 22 | $206.60 | |
| 99072 | <1% | 559 | $87.50 | |
| 88720 | <1% | 14 | $69.64 | |
| 99000 | <1% | 208 | $63.88 | |
| 90633 | <1% | 15 | $39.32 | |
| 91307 | 0% | 669 | $0.00 | |
| 91308 | 0% | 12 | $0.00 | |
| 90671 | 0% | 43 | $0.00 | |
| 91300 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWASLI, BONITA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Valley View Hospital Association | Glenwood Springs, CO | $57K |
| Valley View Hospital Association | Glenwood Springs, CO | $49K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.